β-Glucan enhances complement-mediated hematopoietic recovery after bone marrow injury

Blood

Volumn 107, Issue 2, 2006, Pages 835-840

  Cramer, Daniel E ^a   Allendorf, Daniel J ^a   Baran, Jarek T ^a   Hansen, Richard ^a   Marroquin, Jose ^a   Li, Bing ^a   Ratajczak, Janina ^a   Ratajczak, Mariusz Z ^a   Yan, Jun ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1,3 GLUCAN; CD11 ANTIGEN; CD11B ANTIGEN; CD18 ANTIGEN; COMPLEMENT FACTOR I; COMPLEMENT RECEPTOR; IMMUNOGLOBULIN M;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ARTICLE; BONE MARROW DISEASE; CELL PROLIFERATION; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; IRRADIATION; LEUKOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL;

EID: 30444440055     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-07-2705     Document Type: Article

References (31)

1. Carroll MC, Fischer MB. Complement and the immune response. Curr Opin Immunol. 1997;9:64-69.
2. Carroll MC. The complement system in regulation of adaptive immunity. Nat Immunol. 2004;5:981-986.
3. Ratajczak J, Reca R, Kucia M, et al. Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow. Blood. 2004;103:2071-2078.
4. Reca R, Mastellos D, Majka M, et al. Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1. Blood. 2003;101:3784-3793.
5. Ratajczak MZ, Reca R, Wysoczynski M, et al. Transplantation studies in C3-deficient animals reveal a novel role of the third complement component (C3) in engraftment of bone marrow cells. Leukemia. 2004;18:1482-1490.
6. Ishida A, Zeng H, Ogawa M. Expression of lineage markers by CD34+ hematopoietic stem cells of adult mice. Exp Hematol. 2002;30:361-365.
7. Velders GA, Pruijt JF, Verzaal P, et al. Enhancement of G-CSF-induced stem cell mobilization by antibodies against the beta 2 integrins LFA-1 and Mac-1. Blood. 2002;100:327-333.
8. Weiser MR, Williams JP, Moore FD Jr, et al. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med. 1996;183:2343-2348.
9. Markiewski MM, Mastellos D, Tudoran R, et al. C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injury. J Immunol. 2004;173:747-754.
10. Yasojima K, Schwab C, McGeer EG, McGeer PL. Human heart generates complement proteins that are upregulated and activated after myocardial infarction. Circ Res. 1998;83:860-869.
11. Zhang M, Austen WG Jr, Chiu I, et al. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc Natl Acad Sci U S A. 2004;101:3886-3891.
12. Xia Y, Ross GD. Generation of recombinant fragments of CD11b expressing the functional betaglucan-binding lectin site of CR3 (CD11b/CD18). J Immunol. 1999;162:7285-7293.
13. Hashimoto K, Suzuki I, Ohsawa M, Oikawa S, Yadomae T. Enhancement of hematopoietic response of mice by intraperitoneal administration of a beta-glucan, SSG, obtained from Sclerotinia sclerotiorum. J Pharmacobiodyn. 1990;13:512-517.
14. Lin H, She YH, Cassileth BR, Sirotnak F, Cunningham-Rundles S. Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro. Int Immunopharmacol. 2004;4:91-99.
15. Liskova A, Wagnerova J, Cervenakova L, Kristofova A, Ferencik M. The effect of soluble glucan derivates on spleen colony-forming units in sublethally irradiated mice. Folia Microbiol (Praha). 1990;35:353-362.
16. Matsuo T, Kurahashi Y, Nishida S, Kumada K, Hayami T, Takagi T. [Granulopoietic effects of lentinan in mice: effects on GM-CFC and 5-FU-induced leukopenia]. Gan To Kagaku Ryoho. 1987;14:1310-1314.
17. Patchen ML, MacVittie TJ. Comparative effects of soluble and particulate glucans on survival in irradiated mice. J Biol Response Mod. 1986;5:45-60.
18. Patchen ML, MacVittie TJ. Hemopoietic effects of intravenous soluble glucan administration. J Immunopharmacol. 1986;8:407-425.
19. Patchen ML, MacVittie TJ, Brook I. Glucan-induced hemopoietic and immune stimulation: therapeutic effects in sublethally and lethally irradiated mice. Methods Find Exp Clin Pharmacol. 1986;8:151-155.
20. Cheung NK, Modak S, Vickers A, Knuckles B. Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies. Cancer Immunol Immunother. 2002;51:557-564.
21. Hong F, Hansen RD, Yan J, et al. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells. Cancer Res. 2003;63:9023-9031.
22. Ross GD, Vetvicka V, Yan J, Xia Y, Vetvickova J. Therapeutic intervention with complement and beta-glucan in cancer. Immunopharmacology. 1999;42:61-74.
23. Patchen ML, Vaudrain T, Correira H, Martin T, Reese D. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan. Exp Hematol. 1998;26:1247-1254.
24. Turnbull JL, Patchen ML, Scadden DT. The polysaccharide, PGG-glucan, enhances human myelopoiesis by direct action independent of and additive to early-acting cytokines. Acta Haematol. 1999;102:66-71.
25. Coxon A, Rieu P, Barkalow FJ, et al. A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity. 1996;5:653-666.
26. Hong F, Yan J, Baran JT, et al. Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J Immunol. 2004;173:797-806.
27. Cain JA, Newman SL, Ross GD. Role of complement receptor type three and serum opsonins in the neutrophil response to yeast. Complement. 1987;4:75-86.
28. Mastellos D, Papadimitriou JC, Franchini S, Tsonis PA, Lambris JD. A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration. J Immunol. 2001;166:2479-2486.
29. Hidalgo A, Peired AJ,Weiss LA, Katayama Y, Frenette PS. The integrin alphaMbeta2 anchors hematopoietic progenitors in the bone marrow during enforced mobilization. Blood. 2004;104:993-1001.
30. Lapidot T, Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol. 2002;30:973-981.
31. Giovino MA, Wang H, Sykes M, Yang YG. Role of VLA-4 and VLA-5 in ex vivo maintenance of human and pig hematopoiesis in human stromasupported long-term cultures. Exp Hematol. 2005;33:363-370.